Department of Medicine 3 – Rheumatology and Immunology

Effects of different serotonin receptor subtype antagonists on the development of cardiac allograft vasculopathy in murine aortic allografts (2018) Gocht A, Distler J, Spriewald B, Ramsperger-Gleixner M, Weyand M, Ensminger SM, Heim C Journal article 5-YEAR EFFICACY AND SAFETY OF APREMILAST TREATMENT IN SUBJECTS WITH PSORIATIC ARTHRITIS: POOLED ANALYSIS OF THE PALACE STUDIES (2018) Kavanaugh A, Gladman DD, Edwards CJ, Schett G, Guerette B, Delev N, Teng L, et al. Conference contribution New molecular mechanisms in the pathophysiology of rheumatic diseases (2018) Distler J Journal article Osteoimmunology-IMMUNOBONE : Regulation of bone by inflammation (2018) Rauner M, Buttgereit F, Distler J, Garbe AI, Herrmann M, Hofbauer L, Hoffmann M, et al. Journal article XIAP AS NOVEL INTEGRATOR OF TGF BETA SIGNALLING AND CANONICAL WNT SIGNALLING IN TISSUE FIBROSIS (2018) Bergmann C, Hallenberger L, Merlevede B, Brandt A, Dees C, Chen CW, Stock M, et al. Conference contribution TGFβ PROMOTES FIBROSIS BY MYST1-DEPENDENT EPIGENETIC REGULATION OF AUTOPHAGY (2018) Zehender A, Lin NY, Stefanica A, Chen CW, Soarel A, Wohlfahrt T, Reuber S, et al. Conference contribution THE AP1 TRANSCRIPTION FACTOR CJUN AMPLIFIES HEDGEHOG-INDUCED FIBROBLAST ACTIVATION AND TISSUE FIBROSIS (2018) Bergmann C, Merlevede B, Beyer C, Hallenberger L, Brandt A, Dees C, Pötter S, et al. Conference contribution TOCILIZUMAB ACHIEVES BETTER REPAIR OF FOCAL BONE EROSIONS THAN TUMOUR NECROSIS FACTOR INHIBITION IN RA PATIENTS - DATA FROM THE PROSPECTIVE REBONE STUDY ON EROSION REPAIR (2018) Schett G, Finze S, Kraus S, Regensburger A, Kocijan R, Rech J Conference contribution What Characterizes Osteoarthritis: Ultrasound-Detected Inflammation but Not Osteophytes Is More Common in Hand Osteoarthritis Than in Painless Bony Enlargements (2018) Gasperi N, Adinolfi A, Kleyer A, Hagen M, Gasperi C, Weger M, Kiechl S, et al. Conference contribution Secukinumab Efficacy in Psoriatic Arthritis: Individual Patient Meta-Analysis of Four Phase 3 Trials in 2049 Patients (2018) Gottlieb AB, Mease PJ, Kirkham B, Nash P, Balsa A, Combe B, Rech J, et al. Conference contribution